A variety of antigens are being tested to target AML blast cells, including CD7, CD19, CD33, CD38, CD44v6, CD70, CD123, CD276, CLL-1, Flt3, and NKG2D [2]. The gene discussed is CD19; the disease is acute myeloid leukemia.